The role of S100 proteins has been widely examined in breast cancer, lung cancer, and melanoma, but pathologic S100 signalling could also be observed in additional cancer types, such as ovarian, colorectal, and pancreatic cancer. This evidence concerns the gene S100A1 and lung cancer.